BRIEF published on 09/26/2024 at 13:46, 2 years ago GUERBET: Availability of the 2024 half-yearly financial report Investors Financial Report Guerbet Medical Imaging Publications
BRIEF published on 09/02/2024 at 13:04, 2 years 1 month ago Guerbet: Half-yearly report on the liquidity contract Liquidity Securities Transactions Half-yearly Report Guerbet
BRIEF published on 07/23/2024 at 17:57, 2 years 2 months ago GUERBET: Number of shares and voting rights as of June 30, 2024 Capital Actions AMF Guerbet Right To Vote
BRIEF published on 06/24/2024 at 12:06, 2 years 3 months ago GUERBET: Number of shares and voting rights as of May 31, 2024 Voting Rights Capital Actions AMF Guerbet
BRIEF published on 05/24/2024 at 17:50, 2 years 4 months ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
PRESS RELEASE published on 05/24/2024 at 17:45, 2 years 4 months ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 2 years 5 months ago Number of Guerbet shares and voting rights as of April 30, 2024 Share Capital Voting Rights Actions Transparency Guerbet
BRIEF published on 03/20/2024 at 18:05, 2 years 7 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 2 years 7 months ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 2 years 7 months ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
Published on 10/22/2026 at 16:00, 4 hours 42 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 6 hours 12 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 6 hours 42 minutes ago Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Published on 10/22/2026 at 14:00, 6 hours 42 minutes ago Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
Published on 10/22/2026 at 13:45, 6 hours 57 minutes ago Karbon-X (OTCQB:KARX) Accelerates High-Margin Transformation in Q1 FY2027: Gross Margin Expands to 32%, Operating Cash Burn Drops 55%, and Deferred Revenue Reaches $4.3 Million
Published on 10/22/2026 at 20:00, 42 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 18:45, 1 hour 57 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:12, 2 hours 30 minutes ago LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:10, 2 hours 32 minutes ago EQS-Adhoc: LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:03, 2 hours 38 minutes ago Voltatron Strengthens Financial Foundation for Further Growth by Securing €14 Million Financing Package
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 2 hours 42 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 2 hours 55 minutes ago Aéroports de Paris SA - 2026 9-month revenue
Published on 10/22/2026 at 17:45, 2 hours 57 minutes ago Third-quarter 2026 : Accor upgrades its EBITDA guidance
